Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LORABID

LORACARBEF

Standard Dose
200MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview LORABID is listed in Drugs@FDA under application 050667 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LORACARBEF Form and strength FOR SUSPENSION;ORAL - 200MG/5ML Sponsor KING PHARMS Submission history Latest submission status date: 2001-09-27 00:00:00.

Structured Monograph

Clinical summary

Approval overview LORABID is listed in Drugs@FDA under application 050667 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LORACARBEF Form and strength FOR SUSPENSION;ORAL - 200MG/5ML Sponsor KING PHARMS Submission history Latest submission status date: 2001-09-27 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.